Showing results (381-390 of 519) with videos related to

Sort By:
Pageof 52
Metabolism: Clinical and Experimental|January 17, 2007
Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta miceMitsuo Tanimoto, Tomohito Gohda, Shigeru Kaneko, et al.
World Journal of Gastroenterology|December 29, 2016
Long-term prognostic impact of circulating tumour cells in gastric cancer patientsHiroaki Ito, Jun Sato, Yukio Tsujino, et al.
Endocrinology, Diabetes & Metabolism|July 1, 2025
Association of the Glycated Albumin-to-Glycated Haemoglobin Ratio With Mortality in Type 2 Diabetes: A Retrospective Cohort AnalysisTomohito Gohda, Nozomu Kamei, Marenao Tanaka, et al.
Scientific Reports|October 19, 2018
Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetesNozomu Kamei, Mami Yamashita, Yuji Nishizaki, et al.
Cancer Letters|January 30, 1997
Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 geneM Sato, H Kawamata, K Harada, et al.
Endocrine Connections|August 8, 2024
Associations between circulating levels of FABP4 and TNF receptors are more evident in patients with type 2 diabetes mellitus than in patients with type 1 diabetes mellitusMarenao Tanaka, Tomohito Gohda, Nozomu Kamei, et al.
Thrombosis Research|August 19, 2006
Identification of inherited macrothrombocytopenias based on mean platelet volume among patients diagnosed with idiopathic thrombocytopeniaFumito Gohda, Hideki Uchiumi, Hiroshi Handa, et al.
Metabolism: Clinical and Experimental|December 5, 2006
Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stressMinfang Zhang, Shinji Hagiwara, Masukazu Matsumoto, et al.
Metabolism Open|September 22, 2025
Independent predictive role of nutritional markers in kidney function decline and mortality in diabetesTomohito Gohda, Nozomu Kamei, Marenao Tanaka, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2005
Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylationShinji Hagiwara, Yuichiro Makita, Leyi Gu, et al.
Pageof 52